Results 151 to 160 of about 29,053 (244)

Targeted Radionuclide Therapy Activates Prodrugs for Treating Metastasis. [PDF]

ACS Cent Sci
Guo Z, Wang X, Han Y, Shen S, Tian P, Hu Y, Ding Z, Fu Q, Liu Z.   +8 more
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy for Neuroendocrine Neoplasms in Germany: a Multi-Institutional Registry Study with Prospective Follow Up on 450 Patients [PDF]

, 2013
Samer Ezziddin, Dieter Hörsch, Alexander Haug, Klaus F. Gratz, Simone Dunkelmann, Bernd J. Krause, Matthias Miederer, Hans‐Jürgen Biersack, Gabriele Pöpperl, Richard P. Baum   +9 more
openalex   +1 more source

Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors. [PDF]

J Neuroendocrinol
Santo G, di Santo G, Cicone F, Virgolini I.   +3 more
europepmc   +1 more source

EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy

, 2010
Carlsson
openalex   +2 more sources

Paralytic Subileus as an Adverse Effect of Amino Acid–Based Nephroprotection in a Patient Undergoing Peptide Receptor Radionuclide Therapy [PDF]

, 2014
Rudolf A. Werner, Joachim Brumberg, Alexander Dierks, Ken Herrmann, Johannes Biko, Andreas K. Buck, Constantin Lapa   +6 more
openalex   +1 more source

Role of Radionuclide Therapy as Adjuvant to Palliative External Beam Radiotherapy for Painful Multiple Skeletal Metastasis

, 2010
Ayşe Hiçsönmez
openalex   +2 more sources

[¹¹¹In-DTPA]octreotide Tumor Uptake in GEPNET Liver Metastases After Intra-Arterial Administration: An Overview of Preclinical and Clinical Observations and Implications for Tumor Radiation Dose After Peptide Radionuclide Therapy [PDF]

, 2014
Stefan Pool, Boen L.R. Kam, Gerben A. Koning, Mark Konijnenberg, Timo L.M. ten Hagen, Woulter A.P. Breeman, Eric P. Krenning, Marion de Jong, Casper H.J. van Eijck   +8 more
openalex   +1 more source

The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy. [PDF]

Front Endocrinol (Lausanne)
Singh A, Sanduleanu S, Kulkarni HR, Langbein T, Lambin P, Baum RP.   +5 more
europepmc   +1 more source

Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to⁶⁸Ga-DOTATATE/-TOC uptake [PDF]

, 2016
Katharina Seystahl, Veit M. Stoecklein, Ulrich Schüller, Elisabeth J. Rushing, Guillaume Nicolas, Niklaus Schäfer, Harun Ilhan, Athina Pangalu, Michael Weller, Jörg‐Christian Tonn, Michael Sommerauer, Nathalie L. Albert   +11 more
openalex   +1 more source

Chronic Prostate Cancer-Related Symptoms and Toxicities Following Stereotactic Body Radiation Therapy: Implications for Future Radionuclide Therapy. [PDF]

Cureus
Kallam D, Gaudian K, Collins R, Zwart Z, Koh MJ, Danner MT, Zwart AL, Kumar D, Simeng S, Gudenkauf L, Fallick M, Esposito G, Gonzalez B, Collins S.   +13 more
europepmc   +1 more source